AARD Aardvark Therapeutics | $5.60
-4.4% | 7/20/2026 | | Reiterated Rating | $6.00 | Neutral | 00.00% | View details for HC Wainwright rating of Aardvark Therapeutics (NASDAQ:AARD) on 7/20/2026 |
ATAI Atai Beckley | $7.19
-0.5% | 7/20/2026 | | Downgrade | $25.00 ➝ $7.50 | Buy ➝ Neutral | 00.00% | View details for HC Wainwright rating of Atai Beckley (NASDAQ:ATAI) on 7/20/2026 |
FDMT 4D Molecular Therapeutics | $11.22
+2.1% | 7/20/2026 | | Reiterated Rating | $36.00 | Buy | 00.00% | View details for HC Wainwright rating of 4D Molecular Therapeutics (NASDAQ:FDMT) on 7/20/2026 |
MLTX MoonLake Immunotherapeutics | $19.11
-2.9% | 7/20/2026 | | Reiterated Rating | $45.00 | Buy | 00.00% | View details for HC Wainwright rating of MoonLake Immunotherapeutics (NASDAQ:MLTX) on 7/20/2026 |
RCUS Arcus Biosciences | $28.35
+3.6% | 7/20/2026 | | Boost Price Target | $32.00 ➝ $45.00 | Buy | 00.00% | View details for HC Wainwright rating of Arcus Biosciences (NYSE:RCUS) on 7/20/2026 |
SLGL Sol-Gel Technologies | $79.98
-3.9% | 7/20/2026 | | Reiterated Rating | $110.00 | Buy | 00.00% | View details for HC Wainwright rating of Sol-Gel Technologies (NASDAQ:SLGL) on 7/20/2026 |
SLNH Soluna | $1.35
+19.0% | 7/20/2026 | | Initiated Coverage | $4.00 | Buy | 00.00% | View details for HC Wainwright rating of Soluna (NASDAQ:SLNH) on 7/20/2026 |
SOPH SOPHiA GENETICS | $6.46
+10.1% | 7/20/2026 | | Initiated Coverage | $12.00 | Buy | 00.00% | View details for HC Wainwright rating of SOPHiA GENETICS (NASDAQ:SOPH) on 7/20/2026 |
TRVI Trevi Therapeutics | $17.24
-9.6% | 7/20/2026 | | Boost Price Target | $21.00 ➝ $24.00 | Buy | 00.00% | View details for HC Wainwright rating of Trevi Therapeutics (NASDAQ:TRVI) on 7/20/2026 |
BWAY Brainsway | $16.63
+5.7% | 7/17/2026 | | Reiterated Rating | $14.00 | Buy | 00.00% | View details for HC Wainwright rating of Brainsway (NASDAQ:BWAY) on 7/17/2026 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. |
GLDG GoldMining | $0.83
-0.7% | 7/17/2026 | | Lower Price Target | $3.75 ➝ $2.75 | Buy | 00.00% | View details for HC Wainwright rating of GoldMining (NYSEAMERICAN:GLDG) on 7/17/2026 |
CBIO Crescent Biopharma | $15.21
+3.1% | 7/16/2026 | | Reiterated Rating | | Neutral | 00.00% | View details for HC Wainwright rating of Crescent Biopharma (NASDAQ:CBIO) on 7/16/2026 |
LEGN Legend Biotech | $23.03
+3.5% | 7/16/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Legend Biotech (NASDAQ:LEGN) on 7/16/2026 |
DRD DRDGOLD | $19.74
-0.8% | 7/16/2026 | | Reiterated Rating | $35.00 | Buy | 00.00% | View details for HC Wainwright rating of DRDGOLD (NYSE:DRD) on 7/16/2026 |
DC Dakota Gold | $4.17
-0.1% | 7/16/2026 | | Boost Price Target | $10.50 ➝ $10.75 | Buy | 00.00% | View details for HC Wainwright rating of Dakota Gold (NYSE:DC) on 7/16/2026 |
DRTS Alpha Tau Medical | $13.72
+1.2% | 7/16/2026 | | Reiterated Rating | $15.00 | Buy | 00.00% | View details for HC Wainwright rating of Alpha Tau Medical (NASDAQ:DRTS) on 7/16/2026 |
HRMY Harmony Biosciences | $33.48
-0.9% | 7/16/2026 | | Reiterated Rating | $55.00 | Buy | 00.00% | View details for HC Wainwright rating of Harmony Biosciences (NASDAQ:HRMY) on 7/16/2026 |
UROY Uranium Royalty | $2.77
-1.6% | 7/16/2026 | | Reiterated Rating | $4.50 | Buy | 00.00% | View details for HC Wainwright rating of Uranium Royalty (NASDAQ:UROY) on 7/16/2026 |
NB NioCorp Developments | $4.19
-1.6% | 7/15/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of NioCorp Developments (NASDAQ:NB) on 7/15/2026 |
NXTC NextCure | $5.40
-9.9% | 7/15/2026 | | Reiterated Rating | $20.00 | Buy | 00.00% | View details for HC Wainwright rating of NextCure (NASDAQ:NXTC) on 7/15/2026 |
PMN Promis Neurosciences | $15.51
+2.1% | 7/15/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Promis Neurosciences (NASDAQ:PMN) on 7/15/2026 |
PRLD Prelude Therapeutics | $4.00
-4.7% | 7/15/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Prelude Therapeutics (NASDAQ:PRLD) on 7/15/2026 |
SMMT Summit Therapeutics | $13.62
-1.3% | 7/15/2026 | | Reiterated Rating | | Neutral | 00.00% | View details for HC Wainwright rating of Summit Therapeutics (NASDAQ:SMMT) on 7/15/2026 |
SPTX Seaport Therapeutics | $20.43
-2.0% | 7/15/2026 | | Initiated Coverage | $50.00 | Buy | 00.00% | View details for HC Wainwright rating of Seaport Therapeutics (NASDAQ:SPTX) on 7/15/2026 |
CELC Celcuity | $89.40
+1.1% | 7/15/2026 | | Boost Price Target | $145.00 ➝ $155.00 | Buy | 00.00% | View details for HC Wainwright rating of Celcuity (NASDAQ:CELC) on 7/15/2026 |
EVO Evotec | $2.00
+2.1% | 7/15/2026 | | Lower Price Target | $7.00 ➝ $4.00 | Buy | 00.00% | View details for HC Wainwright rating of Evotec (NASDAQ:EVO) on 7/15/2026 |
UMAC Unusual Machines | $17.39
+2.7% | 7/15/2026 | | Initiated Coverage | $42.00 | Buy | 00.00% | View details for HC Wainwright rating of Unusual Machines (NYSEAMERICAN:UMAC) on 7/15/2026 |
ANGO AngioDynamics | $13.66
+1.1% | 7/15/2026 | | Boost Price Target | $16.00 ➝ $19.00 | Buy | 00.00% | View details for HC Wainwright rating of AngioDynamics (NASDAQ:ANGO) on 7/15/2026 |
AXSM Axsome Therapeutics | $224.95
-2.2% | 7/15/2026 | | Reiterated Rating | $290.00 | Buy | 00.00% | View details for HC Wainwright rating of Axsome Therapeutics (NASDAQ:AXSM) on 7/15/2026 |
COCH Envoy Medical | $0.67
-4.4% | 7/15/2026 | | Reiterated Rating | $2.50 | Buy | 00.00% | View details for HC Wainwright rating of Envoy Medical (NASDAQ:COCH) on 7/15/2026 |
CRVO CervoMed | $2.83
-8.1% | 7/15/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of CervoMed (NASDAQ:CRVO) on 7/15/2026 |
SNDX Syndax Pharmaceuticals | $22.54
-1.1% | 7/15/2026 | | Reiterated Rating | $40.00 | Buy | 00.00% | View details for HC Wainwright rating of Syndax Pharmaceuticals (NASDAQ:SNDX) on 7/15/2026 |
SPTX Seaport Therapeutics | $20.43
-2.0% | 7/15/2026 | | Initiated Coverage | $50.00 | Buy | 00.00% | View details for HC Wainwright rating of Seaport Therapeutics (NASDAQ:SPTX) on 7/15/2026 |
UMAC Unusual Machines | $17.39
+2.7% | 7/15/2026 | | Initiated Coverage | $42.00 | Buy | 00.00% | View details for HC Wainwright rating of Unusual Machines (NYSEAMERICAN:UMAC) on 7/15/2026 |
CLSK Cleanspark | $14.60
+12.1% | 7/14/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Cleanspark (NASDAQ:CLSK) on 7/14/2026 |
ONCY Oncolytics Biotech | $0.84
-2.1% | 7/14/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Oncolytics Biotech (NASDAQ:ONCY) on 7/14/2026 |
ERAS Erasca | $19.17
+0.0% | 7/14/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Erasca (NASDAQ:ERAS) on 7/14/2026 |
MBOT Microbot Medical | $1.80
+2.6% | 7/14/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Microbot Medical (NASDAQ:MBOT) on 7/14/2026 |
BMRN BioMarin Pharmaceutical | $59.45
-0.2% | 7/14/2026 | | Reiterated Rating | | Neutral | 00.00% | View details for HC Wainwright rating of BioMarin Pharmaceutical (NASDAQ:BMRN) on 7/14/2026 |
INCY Incyte | $115.41
-1.6% | 7/14/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Incyte (NASDAQ:INCY) on 7/14/2026 |
It Has Happened Before and the DOJ Just Confirmed It Is Happening Again (Ad) While the trade war grabs headlines, the Department of Justice has quietly argued in court that cash may not be legally yours. If Washington can seize imported goods without warning, your bank account could be the next target.
Governments rarely announce moves against private wealth in advance. A free Wealth Defense Guide outlines how to move your savings out of reach before the window closes. Get your free Wealth Defense Guide and protect your savings now |
CRDL Cardiol Therapeutics | $1.22
+0.4% | 7/14/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Cardiol Therapeutics (NASDAQ:CRDL) on 7/14/2026 |
LCTX Lineage Cell Therapeutics | $1.11
-4.7% | 7/14/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Lineage Cell Therapeutics (NYSEAMERICAN:LCTX) on 7/14/2026 |
AGEN Agenus | $5.01
-0.1% | 7/13/2026 | | Boost Price Target | $23.00 ➝ $30.00 | Buy | 00.00% | View details for HC Wainwright rating of Agenus (NASDAQ:AGEN) on 7/13/2026 |
ALNY Alnylam Pharmaceuticals | $274.25
+2.5% | 7/13/2026 | | Boost Price Target | $470.00 ➝ $485.00 | Buy | 00.00% | View details for HC Wainwright rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 7/13/2026 |
APYX Apyx Medical | $4.10
-4.3% | 7/13/2026 | | Initiated Coverage | $7.00 | Buy | 00.00% | View details for HC Wainwright rating of Apyx Medical (NASDAQ:APYX) on 7/13/2026 |
BBIO BridgeBio Pharma | $81.46
+0.1% | 7/13/2026 | | Boost Price Target | $110.00 ➝ $120.00 | Buy | 00.00% | View details for HC Wainwright rating of BridgeBio Pharma (NASDAQ:BBIO) on 7/13/2026 |
COAG Hemab Therapeutics | $49.45
+0.3% | 7/13/2026 | | Boost Price Target | $40.00 ➝ $52.00 | Buy | 00.00% | View details for HC Wainwright rating of Hemab Therapeutics (NASDAQ:COAG) on 7/13/2026 |
OKYO OKYO Pharma | $1.37
-4.1% | 7/13/2026 | | Lower Price Target | $7.00 ➝ $5.00 | Buy | 00.00% | View details for HC Wainwright rating of OKYO Pharma (NASDAQ:OKYO) on 7/13/2026 |
TGTX TG Therapeutics | $54.43
-0.8% | 7/13/2026 | | Boost Price Target | $70.00 ➝ $77.00 | Buy | 00.00% | View details for HC Wainwright rating of TG Therapeutics (NASDAQ:TGTX) on 7/13/2026 |
TRAX First Tracks Biotherapeutics | $37.24
+2.0% | 7/10/2026 | | Boost Price Target | $30.00 ➝ $44.00 | Buy | 00.00% | View details for HC Wainwright rating of First Tracks Biotherapeutics (NASDAQ:TRAX) on 7/10/2026 |
NRIX Nurix Therapeutics | $22.88
-1.1% | 7/10/2026 | | Boost Price Target | $32.00 ➝ $34.00 | Buy | 00.00% | View details for HC Wainwright rating of Nurix Therapeutics (NASDAQ:NRIX) on 7/10/2026 |
AG First Majestic Silver | $15.92
+0.7% | 7/10/2026 | | Lower Price Target | $30.75 ➝ $26.00 | Buy | 00.00% | View details for HC Wainwright rating of First Majestic Silver (NYSE:AG) on 7/10/2026 |
IONS Ionis Pharmaceuticals | $53.15
-2.3% | 7/10/2026 | | Lower Price Target | $130.00 ➝ $125.00 | Buy | 00.00% | View details for HC Wainwright rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 7/10/2026 |
URGN Urogen Pharma | $41.16
+2.3% | 7/9/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Urogen Pharma (NASDAQ:URGN) on 7/9/2026 |
IMNM Immunome | $22.27
-0.2% | 7/9/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Immunome (NASDAQ:IMNM) on 7/9/2026 |
RMTI Rockwell Medical | $6.35
+3.7% | 7/9/2026 | | Reiterated Rating | $2.00 ➝ $20.00 | Buy | 00.00% | View details for HC Wainwright rating of Rockwell Medical (NASDAQ:RMTI) on 7/9/2026 |
CRVO CervoMed | $2.83
-8.1% | 7/9/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of CervoMed (NASDAQ:CRVO) on 7/9/2026 |
DTIL Precision BioSciences | $7.35
-6.7% | 7/9/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Precision BioSciences (NASDAQ:DTIL) on 7/9/2026 |
ELVN Enliven Therapeutics | $52.16
-2.0% | 7/9/2026 | | Boost Price Target | $56.00 ➝ $64.00 | Buy | 00.00% | View details for HC Wainwright rating of Enliven Therapeutics (NASDAQ:ELVN) on 7/9/2026 |
EXK Endeavour Silver | $7.46
+0.6% | 7/9/2026 | | Reiterated Rating | $17.00 | Buy | 00.00% | View details for HC Wainwright rating of Endeavour Silver (NYSE:EXK) on 7/9/2026 |
MSLE Satellos Bioscience | $8.41
-6.0% | 7/9/2026 | | Boost Price Target | $11.00 ➝ $18.00 | Buy | 00.00% | View details for HC Wainwright rating of Satellos Bioscience (NASDAQ:MSLE) on 7/9/2026 |
NKLR Terra Innovatum Global S.R.L. | $5.07
+10.5% | 7/9/2026 | | Reiterated Rating | $25.00 | Buy | 00.00% | View details for HC Wainwright rating of Terra Innovatum Global S.R.L. (NASDAQ:NKLR) on 7/9/2026 |
PLYX Polaryx Therapeutics | $2.31
+1.3% | 7/9/2026 | | Initiated Coverage | $7.00 | Buy | 00.00% | View details for HC Wainwright rating of Polaryx Therapeutics (NASDAQ:PLYX) on 7/9/2026 |
TARS Tarsus Pharmaceuticals | $56.69
-5.3% | 7/9/2026 | | Reiterated Rating | $88.00 | Buy | 00.00% | View details for HC Wainwright rating of Tarsus Pharmaceuticals (NASDAQ:TARS) on 7/9/2026 |
AXSM Axsome Therapeutics | $224.95
-2.2% | 7/8/2026 | | Reiterated Rating | $290.00 | Buy | 00.00% | View details for HC Wainwright rating of Axsome Therapeutics (NASDAQ:AXSM) on 7/8/2026 |
CMPS Compass Pathways | $11.70
-5.3% | 7/8/2026 | | Reiterated Rating | $70.00 | Buy | 00.00% | View details for HC Wainwright rating of Compass Pathways (NASDAQ:CMPS) on 7/8/2026 |
CRSP CRISPR Therapeutics | $47.30
-1.0% | 7/8/2026 | | Reiterated Rating | $80.00 | Buy | 00.00% | View details for HC Wainwright rating of CRISPR Therapeutics (NASDAQ:CRSP) on 7/8/2026 |
MGTX MeiraGTx | $12.14
-2.4% | 7/8/2026 | | Reiterated Rating | $20.00 | Buy | 00.00% | View details for HC Wainwright rating of MeiraGTx (NASDAQ:MGTX) on 7/8/2026 |
TII Titan Mining | $2.04
-0.7% | 7/8/2026 | | Reiterated Rating | $6.50 | Buy | 00.00% | View details for HC Wainwright rating of Titan Mining (NYSEAMERICAN:TII) on 7/8/2026 |
TRAX First Tracks Biotherapeutics | $37.24
+2.0% | 7/8/2026 | | Reiterated Rating | $30.00 | Buy | 00.00% | View details for HC Wainwright rating of First Tracks Biotherapeutics (NASDAQ:TRAX) on 7/8/2026 |
VERA Vera Therapeutics | $36.99
-3.9% | 7/8/2026 | | Boost Price Target | $110.00 ➝ $125.00 | Buy | 00.00% | View details for HC Wainwright rating of Vera Therapeutics (NASDAQ:VERA) on 7/8/2026 |
BEAM Beam Therapeutics | $26.37
-4.2% | 7/7/2026 | | Reiterated Rating | $80.00 | Buy | 00.00% | View details for HC Wainwright rating of Beam Therapeutics (NASDAQ:BEAM) on 7/7/2026 |
CRNX Crinetics Pharmaceuticals | $83.87
+0.0% | 7/7/2026 | | Downgrade | $81.00 ➝ $85.00 | Buy ➝ Hold | 00.00% | View details for HC Wainwright rating of Crinetics Pharmaceuticals (NASDAQ:CRNX) on 7/7/2026 |
LENZ LENZ Therapeutics | $5.01
-3.4% | 7/7/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of LENZ Therapeutics (NASDAQ:LENZ) on 7/7/2026 |
LGO Largo | $0.61
-2.1% | 7/7/2026 | | Lower Price Target | $2.80 ➝ $2.40 | Buy | 00.00% | View details for HC Wainwright rating of Largo (NYSE:LGO) on 7/7/2026 |
TBPH Theravance Biopharma | $16.91
-0.1% | 7/7/2026 | | Downgrade | $15.00 ➝ $17.00 | Buy ➝ Neutral | 00.00% | View details for HC Wainwright rating of Theravance Biopharma (NASDAQ:TBPH) on 7/7/2026 |
TLX Telix Pharmaceuticals | $10.52
+0.5% | 7/7/2026 | | Reiterated Rating | $20.00 | Buy | 00.00% | View details for HC Wainwright rating of Telix Pharmaceuticals (NASDAQ:TLX) on 7/7/2026 |
OKTA Okta | $150.53
+0.8% | 7/6/2026 | | Initiated Coverage | | Buy | 00.00% | View details for HC Wainwright rating of Okta (NASDAQ:OKTA) on 7/6/2026 |
MOLN Molecular Partners | $4.06
+4.1% | 7/6/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Molecular Partners (NASDAQ:MOLN) on 7/6/2026 |
GKOS Glaukos | $156.75
-0.1% | 7/6/2026 | | Initiated Coverage | $168.00 | Buy | 00.00% | View details for HC Wainwright rating of Glaukos (NYSE:GKOS) on 7/6/2026 |
FF First Mining Gold | C$0.60
-1.6% | 7/6/2026 | | Boost Price Target | C$1.20 ➝ C$1.40 | | 00.00% | View details for HC Wainwright rating of First Mining Gold (TSE:FF) on 7/6/2026 |
GKOS Glaukos | $156.75
-0.1% | 7/6/2026 | | Initiated Coverage | $168.00 | Buy | 00.00% | View details for HC Wainwright rating of Glaukos (NYSE:GKOS) on 7/6/2026 |
RVMD Revolution Medicines | $182.14
-2.2% | 7/6/2026 | | Reiterated Rating | $195.00 | Buy | 00.00% | View details for HC Wainwright rating of Revolution Medicines (NASDAQ:RVMD) on 7/6/2026 |
TGTX TG Therapeutics | $54.43
-0.8% | 7/6/2026 | | Reiterated Rating | $70.00 | Buy | 00.00% | View details for HC Wainwright rating of TG Therapeutics (NASDAQ:TGTX) on 7/6/2026 |
KR Kroger | $58.37
-0.8% | 7/2/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Kroger (NYSE:KR) on 7/2/2026 |
BWAY Brainsway | $16.63
+5.7% | 7/2/2026 | | Reiterated Rating | $17.00 | Buy | 00.00% | View details for HC Wainwright rating of Brainsway (NASDAQ:BWAY) on 7/2/2026 |
EXEL Exelixis | $55.75
-0.3% | 7/2/2026 | | Reiterated Rating | $56.00 | Buy | 00.00% | View details for HC Wainwright rating of Exelixis (NASDAQ:EXEL) on 7/2/2026 |
GMAB Genmab A/S | $27.95
-2.7% | 7/2/2026 | | Boost Price Target | $38.00 ➝ $40.00 | Buy | 00.00% | View details for HC Wainwright rating of Genmab A/S (NASDAQ:GMAB) on 7/2/2026 |
LRMR Larimar Therapeutics | $3.84
+3.6% | 7/2/2026 | | Initiated Coverage | $10.00 | Buy | 00.00% | View details for HC Wainwright rating of Larimar Therapeutics (NASDAQ:LRMR) on 7/2/2026 |
ACIU AC Immune | $2.24
+1.6% | 7/1/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of AC Immune (NASDAQ:ACIU) on 7/1/2026 |
Trump's New Dollar (Ad) Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening.
The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result. Watch the free briefing and see the three steps to prepare today |
NAGE Niagen Bioscience | $3.34
+1.7% | 7/1/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Niagen Bioscience (NASDAQ:NAGE) on 7/1/2026 |
RGNX REGENXBIO | $10.58
+7.0% | 7/1/2026 | | Reiterated Rating | $26.00 | Buy | 00.00% | View details for HC Wainwright rating of REGENXBIO (NASDAQ:RGNX) on 7/1/2026 |
AKBA Akebia Therapeutics | $1.28
-4.9% | 7/1/2026 | | Reiterated Rating | $6.00 | Buy | 00.00% | View details for HC Wainwright rating of Akebia Therapeutics (NASDAQ:AKBA) on 7/1/2026 |
ARWR Arrowhead Pharmaceuticals | $71.76
-3.4% | 7/1/2026 | | Reiterated Rating | $100.00 | Buy | 00.00% | View details for HC Wainwright rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 7/1/2026 |
ATCX Atlas Technical Consultants | $3.07
-3.2% | 7/1/2026 | | Reiterated Rating | $13.75 | Buy | 00.00% | View details for HC Wainwright rating of Atlas Technical Consultants (NASDAQ:ATCX) on 7/1/2026 |
GANX Gain Therapeutics | $1.65
-3.8% | 7/1/2026 | | Reiterated Rating | $8.00 | Buy | 00.00% | View details for HC Wainwright rating of Gain Therapeutics (NASDAQ:GANX) on 7/1/2026 |
NAK Northern Dynasty Minerals | $1.61
-1.5% | 7/1/2026 | | Reiterated Rating | $2.50 | Buy | 00.00% | View details for HC Wainwright rating of Northern Dynasty Minerals (NYSEAMERICAN:NAK) on 7/1/2026 |
PCRX Pacira BioSciences | $25.40
-0.8% | 7/1/2026 | | Reiterated Rating | $38.00 | Buy | 00.00% | View details for HC Wainwright rating of Pacira BioSciences (NASDAQ:PCRX) on 7/1/2026 |
SEPN Septerna | $32.62
-2.4% | 7/1/2026 | | Reiterated Rating | $40.00 | Buy | 00.00% | View details for HC Wainwright rating of Septerna (NASDAQ:SEPN) on 7/1/2026 |
XPL Solitario Resources | $0.74
-0.9% | 7/1/2026 | | Reiterated Rating | $1.20 | Buy | 00.00% | View details for HC Wainwright rating of Solitario Resources (NYSEAMERICAN:XPL) on 7/1/2026 |
